Miko Edit, Czimmerer Zsolt, Csánky Eszter, Boros Gábor, Buslig Júlia, Dezso Balázs, Scholtz Beáta
Department of Biochemistry and Molecular Biology, University of Debrecen Medical and Health Science Center, Debrecen, Hungary.
Exp Lung Res. 2009 Oct;35(8):646-64. doi: 10.3109/01902140902822312.
Expression of microRNAs (miRNAs) is characteristically altered in cancer, and they may play a role in cancer development and progression. The authors performed microarray and real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) analyses to determine the miRNA expression profile of primary small cell lung cancer. Here we show that at least 24 miRNAs are differentially expressed between normal lung and primary small cell lung cancer (SCLC) tumors. These include miR-301, miR-183/96/182, miR-126, and miR-223, which are microRNAs deregulated in other tumor types as well; and other miRNAs, such as miR-374 and miR-210, not previously reported in association with lung cancer. The aberrant miRNA profile of SCLC may offer new insights in the biology of this aggressive tumor, and could potentially provide novel diagnostic markers.
微小RNA(miRNA)的表达在癌症中呈现出特征性改变,并且它们可能在癌症的发生和发展中发挥作用。作者进行了微阵列和实时定量逆转录聚合酶链反应(RT-PCR)分析,以确定原发性小细胞肺癌的miRNA表达谱。在此我们表明,正常肺组织和原发性小细胞肺癌(SCLC)肿瘤之间至少有24种miRNA存在差异表达。这些包括miR-301、miR-183/96/182、miR-126和miR-223,它们在其他肿瘤类型中也存在失调;以及其他miRNA,如miR-374和miR-210,此前未报道与肺癌相关。SCLC异常的miRNA谱可能为这种侵袭性肿瘤的生物学特性提供新的见解,并有可能提供新的诊断标志物。